Literature DB >> 20032578

Current trends in lifestyle-related disease management by general practitioners: a report from the "Heart Care Network" groups.

.   

Abstract

AIMS: In Japan, it is believed that guidelines for lifestyle-related disease are used in routine clinical practice, however, there are few reports on the actual rate of healthcare conducted in accordance with these guidelines by general practitioners and on their usefulness in preventing cardiovascular events. Therefore, the Heart Care Network (HCN) groups were organized mainly by general practitioners treating lifestyle diseases in 62 areas of Japan.
METHODS: The HCN has collected data on lifestyle diseases in high-risk patients in routine practices and investigated management conditions, guideline target achievement rates and medication. Additionally, the incidence of cardiovascular events was assessed.
RESULTS: We analyzed 14,064 cases. The lipid profile, blood pressure, glycemic control were significantly improved over the 3 years. The incidence of cardiovascular events were significantly reduced by the achievement of target LDL cholesterol, systolic blood pressure and hemoglobin A1c and even after adjustment for age, gender, history of myocardial infarction, the reduction of these lifestyle-related parameters remains significant.
CONCLUSION: These results revealed the current trends in the healthcare activities of general practitioners, the management conditions for lifestyle diseases in CHD high-risk patients and their effects on reducing cardiovascular events.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20032578     DOI: 10.5551/jat.2352

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  3 in total

Review 1.  Novel treatment approaches in hypertensive type 2 diabetic patients.

Authors:  Yaniel Castro Torres; Richard E Katholi
Journal:  World J Diabetes       Date:  2014-08-15

2.  Antihypertensive efficacy of the losartan/hydrochlorothiazide combination and its effect on plasma B-type natriuretic peptide in hypertensive patients uncontrolled by angiotensin II type 1 receptor antagonist-based therapy: a multicentre prospective observational study.

Authors:  Hiroshi Meno; Tetsuji Inou; Michiko Tanaka; Yoshihiro Tsuchiya; Yuhei Shiga; Kenji Kobayashi; Yuichiro Nakamura; Takeaki Ota; Ichiro Kubara
Journal:  Clin Drug Investig       Date:  2012-03-01       Impact factor: 2.859

3.  Cardiovascular risk management with liaison critical path in Japan: its effects on implementation of evidence-based prevention in practice.

Authors:  Morihiro Matsuda; Manami Akizuki; Orie Nishimoto; Kei Nakamoto; Hirohiko Nishiyama; Ritsu Tamura; Toshiharu Kawamoto
Journal:  J Clin Med Res       Date:  2012-03-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.